January 3, 2026
Tag: research
May 6, 2022
Leading researchers provide insights on aggressive cancers at scientific symposium
UNC Lineberger’s 45th annual Scientific Symposium featured talks on the latest research on pancreatic cancer, tumor microenvironments, metastatic disease and immunotherapy.
February 25, 2022
GEN: Novel Therapeutic Approach against Cancer Revealed
October 13, 2021
WRAL: Duke, UNC teams getting $1.5 million for breast cancer research will study vaccines, death rates in Black women
August 30, 2021
Chemotherapy plus immunotherapy before surgery is beneficial for invasive bladder cancer outcomes
Tracy Rose, MD, MPH, Matthew Milowsky, MD, and colleagues report that the regimen reduced the invasiveness of the cancer in 56% of patients in a phase II clinical trial.
August 16, 2021
Experimental drug that boosts immunotherapy shows promise in bladder cancer study
William Kim, MD, and colleagues have published findings that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission in laboratory models.
August 10, 2021
Hirschey awarded NIH career development grant to study approaches for improving outcomes for African American colon cancer patients
Rachel Hirschey, PhD, RN, will use the grant to create a behavioral intervention to increase physical activity among African Americans being treated for colorectal cancer.
August 9, 2021
New program will aid family, friends who provide crucial support for patients with cancer
Erin Kent, PhD, and Eliza (Leeza) Park, MD, are co-directing a project to help alleviate the burden that informal care places on caregivers, especially those in rural areas.
July 27, 2021
Patients with advanced bladder cancer could benefit from immunotherapy regardless of gene mutation status
Led by William Kim, MD, and colleagues, this research has important implications for patients who have not been offered immunotherapy because of their genetic profiles.
July 21, 2021
Study estimates costs of treating and living with metastatic breast cancer will more than double between 2015 and 2030, due to increase in cases among younger women
Stephanie Wheeler, PhD, MPH, and Justin Trogdon, PhD, are co-authors of a study building upon previous metastatic breast cancer research on medical and productivity costs.